Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Texas Instruments $1.2 billion notes offering
We advised Texas Instruments on its investment-grade debt offering
Kenvue $750 million senior notes offering
The investment-grade notes are due 2032
Medallion Bank preferred stock offering
The preferred stock is listed on the Nasdaq Capital Market
Strategy $2.1 billion perpetual strife preferred stock at-the-market offering
The perpetual strife preferred stock is listed on the Nasdaq Global Select Market
Qualcomm $1.5 billion notes offering
The investment-grade notes are due 2030, 2032 and 2035
Equinix €1.5 billion green bond offering
We advised Equinix on the investment-grade notes offering
Uber Technologies $1.15 billion exchangeable notes offering
The 0% exchangeable senior notes are due 2028
Atara Biotherapeutics registered direct offering
The stock is listed on Nasdaq
Shift4 Payments $550 million and €680 million notes offerings
The high-yield notes are part of the financing for Shift4 Payments’ acquisition of Global Blue Group Holdings
Akamai Technologies $1.725 billion convertible senior notes offering
The convertible senior notes are due 2033